John Wu
About John Wu
John Wu is the QC Director at BeiGene in Suzhou, Jiangsu, China, with extensive experience in pharmaceutical quality control and research.
Title
John Wu currently holds the position of QC Director at BeiGene, located in Suzhou, Jiangsu, China. In this role, he oversees quality control processes and ensures the GMP compliance of drug manufacturing operations.
Company
John Wu works at BeiGene, a global biotechnology company focused on developing and commercializing innovative medicines. At BeiGene, he is instrumental in managing quality control efforts for anticancer drug candidates.
Education and Expertise
John Wu studied Pharmaceutical Quality Control at the Academy of Applied Pharmaceutical Sciences. Additionally, he earned a Ph.D. in Immunology from China Agricultural University. He possesses vast expertise in chemical compound analysis, microbiological testing, method development, and validation for GMP compliance.
Career Background
John Wu has extensive experience in the pharmaceutical industry. Before his current role at BeiGene, he worked at Thermo Fisher (Patheon) for nine years as a Finishing Products Research Scientist and one year as a Raw Material Research Scientist. He also served as a Scientist at Quality Compliance Laboratories (QCL) for 11 months.
Achievements
John Wu successfully led quality control for anticancer new drug candidates, focusing on the physi-chemical analysis and microbiological tests of API, drug products, and placebos. He organized method development, validation, and verification for GMP compliance and IND/NDA filing. He also provided microbiological tests and environmental control support for new biological antibody drug products and collaborated with chemical manufacture in-process control teams to optimize analytical methods.